Pharvaris N.V. (PHVS) Insider Trading

Over the last 3 months, PHVS insiders made 0 open-market buys and 39 sales, a net sale of -$8.0M (SEC Form 4). Over the last 6 months, 81 institutions increased and 53 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
39
Net (3m)
-$8.0M
Insider trades by month Buys Sells
Apr
May
Jun
Context3-month price +22.4%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Jun 29, 2026Lu Pengofficer: Chief Medical OfficerOption14,700$2.59
Jun 29, 2026Lu Pengofficer: Chief Medical OfficerSell3,400$35.09
Jun 29, 2026Lu Pengofficer: Chief Medical OfficerSell11,600$34.45
Jun 29, 2026Lu Pengofficer: Chief Medical OfficerOption15,000$2.59
Jun 29, 2026Schikan Johannes Gerardus Christiaan PetrusdirectorSell2,400$35.10
Jun 29, 2026Lesage Anneofficer: Chief Early DevelopmentSell2,300$35.12
Jun 29, 2026Lesage Anneofficer: Chief Early DevelopmentOption900$8.05
Jun 29, 2026Lesage Anneofficer: Chief Early DevelopmentOption1,400$2.59
Jun 29, 2026Lu Pengofficer: Chief Medical OfficerSell14,700$34.00
Jun 23, 2026Lu Pengofficer: Chief Medical OfficerSell300$34.00
Jun 23, 2026Lu Pengofficer: Chief Medical OfficerOption300$2.59
Jun 17, 2026Modig Berndtdirector, officer: Chief Executive OfficerSell100$31.46
Jun 17, 2026Modig Berndtdirector, officer: Chief Executive OfficerSell2,191$31.05
Jun 16, 2026Lu Pengofficer: Chief Medical OfficerTax117$32.20
Jun 15, 2026Lu Pengofficer: Chief Medical OfficerTax109$31.51
Jun 8, 2026Nijdam Annaofficer: Principal Accounting OfficerSell2,670$30.87
May 26, 2026Nijdam Annaofficer: Principal Accounting OfficerOption1,829$20.00
May 26, 2026Nassif David W.officer: CFO / CLOSell10,000$30.31
May 26, 2026Nijdam Annaofficer: Principal Accounting OfficerSell5,501$30.74
May 26, 2026Nijdam Annaofficer: Principal Accounting OfficerOption5,501$20.00
May 26, 2026Nijdam Annaofficer: Principal Accounting OfficerSell1,829$30.60
May 26, 2026Monges VivianedirectorSell9,667$30.29
May 22, 2026Bjork ElisabethdirectorSell10,000$29.32
May 22, 2026Bjork ElisabethdirectorOption10,000$8.05
May 20, 2026Modig Berndtdirector, officer: Chief Executive OfficerSell2,292$29.22
May 19, 2026Abele Stefan Andreasofficer: Chief Technical Ops OfficerSell8,748$29.82
May 19, 2026Souverijns Wimofficer: Chief Commercial OfficerSell10,000$29.92
May 19, 2026Glassman RobertdirectorSell5,333$29.83
May 19, 2026Glassman RobertdirectorOption5,333$22.31
May 19, 2026Glassman RobertdirectorSell4,667$29.82

Source: PHVS SEC Form 4 filings, latest Jun 29, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their PHVS positions over the last 6 months (SEC Form 13F).

Increased
81
New positions
37
Reduced
53
Sold out
12
Largest moves
InstitutionActionSharesFiled
GENERAL ATLANTIC, L.P.Unchanged8.0MMay 15, 2026
GENERAL ATLANTIC, L.P.Unchanged8.0MFeb 17, 2026
FMR LLCUnchanged6.4MFeb 17, 2026
FMR LLCReduced6.3MMay 15, 2026
FORESITE CAPITAL MANAGEMENT IV, LLCUnchanged4.8MFeb 17, 2026
FORESITE CAPITAL MANAGEMENT IV, LLCUnchanged4.8MMay 15, 2026
VENBIO PARTNERS LLCUnchanged4.6MMay 15, 2026
VENBIO PARTNERS LLCUnchanged4.6MFeb 17, 2026
VIKING GLOBAL INVESTORS LPUnchanged3.7MFeb 17, 2026
VIKING GLOBAL INVESTORS LPUnchanged3.7MMay 15, 2026
EQT FUND MANAGEMENT S.A R.L.Unchanged3.4MMay 14, 2026
EQT FUND MANAGEMENT S.A R.L.Unchanged3.4MFeb 11, 2026
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)Increased3.1MFeb 17, 2026
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)Unchanged3.1MMay 15, 2026
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLCReduced2.8MFeb 17, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.